Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Degradation of rubella virus envelope components.

Literature DB >> 7425848

Degradation of rubella virus envelope components.

Abstract

Tween-ether treatment of rubella virus, which has no effect on the antigenic and electrophoretic properties of the two envelope glycoproteins, destroys infectivity and enhances haemagglutinating activity. Trypsin treatment alters the electrophoretic pattern of the envelope glycoproteins so that the VPI peak is no longer evident and the VPII peak is reduced. At the same time, both the properties of haemagglutination and infectivity are inactivated but the capacity to combine with neutralizing antibody is retained, which suggests that VPII may be responsible for inducing the production of neutralizing antibody.

Entities: Chemical Species

Mesh：

Substances：

Year: 1980 PMID： 7425848 DOI： 10.1007/bf01340535

Source DB: PubMed Journal: Arch Virol ISSN： 0304-8608 Impact factor: 2.574

15 in total

1. Hemagglutination by measles virus. 4. A simple procedure for production of high potency antigen for hemagglutination-inhibition (HI) tests.

Authors: E NORRBY
Journal: Proc Soc Exp Biol Med Date: 1962-12

2. Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors: C M BRADSTREET; C E TAYLOR
Journal: Mon Bull Minist Health Public Health Lab Serv Date: 1962-05

3. Nature and function of the structural phospholipids of an arbovirus.

Authors: R M Friedman; I Pastan
Journal: J Mol Biol Date: 1969-02-28 Impact factor: 5.469

4. Physical and immunologic properties of rubella antigens.

Authors: N J Schmidt; E H Lennette; P S Gee; J Dennis
Journal: J Immunol Date: 1968-04 Impact factor: 5.422

5. Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture.

Authors: A Vaheri; W D Sedwick; S A Plotkin; R Maes
Journal: Virology Date: 1965-10 Impact factor: 3.616

6. Radioimmunoassay for antibodies to rubella virus and its ribonucleoprotein component.

Authors: L Ho-Terry; A Cohen
Journal: J Med Microbiol Date: 1979-11 Impact factor: 2.472

7. Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing.

Authors: J M Dalrymple; S Schlesinger; P K Russell
Journal: Virology Date: 1976-01 Impact factor: 3.616

8. Small size rubella virus antigens and soluble immune complexes: analysis by the platelet aggregation technique.

Authors: A Vaheri; T Vesikari
Journal: Arch Gesamte Virusforsch Date: 1971

9. Rubella complement-fixing antigens derived from the fluid and cellular phases of infected BHK-21 cells: extraction of cell-associated antigen with alkaline buffers.

Authors: N J Schmidt; E H Lennette
Journal: J Immunol Date: 1966-12 Impact factor: 5.422

10. Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.

Authors: H Liebhaber
Journal: J Immunol Date: 1970-04 Impact factor: 5.422

19 in total

1. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

Authors: K Y Green; P H Dorsett
Journal: J Virol Date: 1986-03 Impact factor: 5.103

Degradation of rubella virus envelope components.

1. Hemagglutination by measles virus. 4. A simple procedure for production of high potency antigen for hemagglutination-inhibition (HI) tests.

2. Technique of complementfixation test applicable to the diagnosis of virus diseases.

3. Nature and function of the structural phospholipids of an arbovirus.

4. Physical and immunologic properties of rubella antigens.

5. Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture.

6. Radioimmunoassay for antibodies to rubella virus and its ribonucleoprotein component.

7. Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing.

8. Small size rubella virus antigens and soluble immune complexes: analysis by the platelet aggregation technique.

9. Rubella complement-fixing antigens derived from the fluid and cellular phases of infected BHK-21 cells: extraction of cell-associated antigen with alkaline buffers.

10. Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.

1. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

2. Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

3. Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus.

4. Immunological characterisation of the rubella E 1 glycoprotein. Brief report.

5. Localization of the rubella E1 epitopes.

6. First trimester prenatal diagnosis of congenital rubella: a laboratory investigation.

7. Differences in antibody responses with rapid agglutination tests for the detection of rubella antibodies.

8. Analysis of rubella virus complement-fixing antigens by polyacrylamide gel electrophoresis.

Review 9. Molecular and Structural Insights into the Life Cycle of Rubella Virus.

10. Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.